San Francisco Treatment Research Center
The San Francisco Treatment Research Center (SFTRC) at the University of California, San Francisco (UCSF), is a Center funded by the National Institute on Drug Abuse conducting a variety of studies focused on innovative treatments for substance abuse. Our research includes both psychosocial and pharmacologic trials in both randomized clinical trial and Phase I development forms. We conduct our work at UCSF and its affiliated sites at the San Francisco Veterans Affairs Medical Center and San Francisco General Hospital and the Habit Abatement Clinic.
"CLINICAL INNOVATIONS IN SUBSTANCE ABUSE TREATMENT"
Friday, May 18, 2012am
The registration for the conference is now at full capacity and CLOSED.
Jewish Community Center of San Francisco
Kanbar Hall
3200 California Street
San Francisco, CA
8:30AM-4:00PM
(Registration check-in from 8:00AM -8:30AM)
Keynote Speaker
There has been a replacement for our keynote speaker Dr. Westley Clark he is unable to attend due to last minute schedule changes.
Wilson Washington, Jr, MS
Public Health Advisor, Center for Substance Abuse Treatment (CSAT/SAMHSA)
“Health Information Technology’s Role in the Integration of Delivery Systems for Primary Care and Substance Abuse”
Speakers for the conference:
Constance Weisner, DrPH, MSW
“Integrating Alcohol and Drug Treatment with Primary Care: A Medical Home Model”
Dieter Meyerhoff, Dr.rer.nat
"What can human brain imaging tell us about addiction and recovery from substance use?"
Lisa Metsch, PhD
“HIV Rapid Testing”
John Straznickas, MD
“Substance Use Disorder/Post Traumatic Stress Disorder –
Moving from Dichotomous to Dialectic”
Afternoon workshops:
A. Promoting Awareness of Motivational Incentives (PAMI): Michael Shopshire, PhD
B. HIV Testing and Counseling: Tim Matheson, PhD
C. Treatment of Co-Occurring PTSD and Substance Use Disorders: John
Straznickas, MD
D. Strategies to Improve Linkages between Substance Abuse Treatment and
Primary Care: Thekla Brumder, PsyD
The conference registration is closed.
Sponsored by the San Francisco Treatment Research Center and Western States Node of NIDA Clinical Treatment Network